Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Manfrini

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Diabetes, Obesity & Metabolism|December 1, 2010
Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral studyA Palermo, N Napoli, S Manfrini, et al.
Diabetes Research and Clinical Practice|July 1, 1996
Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitusR Testa, A R Bonfigli, L Piantanelli, et al.
Gerontology|April 5, 2001
Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patientsC Pieri, R Testa, M Marra, et al.
Minerva Chirurgica|May 31, 1986
[Crohn's disease and the surgeon]A Santini, S Manfrini, E Morsiani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|October 30, 1985
[Kinetic evaluation of the formation of glycosylated hemoglobin]S Manfrini, A Cavarape, A Festa, et al.
Life Sciences|January 1, 1996
Glycosylated hemoglobin and fructosamines: does their determination really reflect the glycemic control in diabetic patients?R Testa, I Testa, S Manfrini, et al.
International Journal of Clinical & Laboratory Research|November 5, 1998
A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complicationsR Testa, A R Bonfigli, C Pieri, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 3, 2000
Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metforminF Gregorio, F Ambrosi, S Manfrini, et al.
Therapeutic Drug Monitoring|June 12, 1999
Determination of plasma metformin by a new cation-exchange HPLC techniqueA R Bonfigli, S Manfrini, F Gregorio, et al.
European Journal of Nuclear Medicine|July 1, 1997
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolismC Cittanti, P Colamussi, M Giganti, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Diabetes, Obesity & Metabolism|December 1, 2010
Buccal spray insulin in subjects with impaired glucose tolerance: the prevoral studyA Palermo, N Napoli, S Manfrini, et al.
Diabetes Research and Clinical Practice|July 1, 1996
Relationship between plasminogen activator inhibitor type-1 plasma levels and the lipoprotein(a) concentrations in non-insulin-dependent diabetes mellitusR Testa, A R Bonfigli, L Piantanelli, et al.
Gerontology|April 5, 2001
Age-dependent changes of serum oxygen radical scavenger capacity and haemoglobin glycosylation in non-insulin-dependent diabetic patientsC Pieri, R Testa, M Marra, et al.
Minerva Chirurgica|May 31, 1986
[Crohn's disease and the surgeon]A Santini, S Manfrini, E Morsiani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|October 30, 1985
[Kinetic evaluation of the formation of glycosylated hemoglobin]S Manfrini, A Cavarape, A Festa, et al.
Life Sciences|January 1, 1996
Glycosylated hemoglobin and fructosamines: does their determination really reflect the glycemic control in diabetic patients?R Testa, I Testa, S Manfrini, et al.
International Journal of Clinical & Laboratory Research|November 5, 1998
A significant relationship between plasminogen activator inhibitor type-1 and lipoprotein(a) in non-insulin-dependent diabetes mellitus without complicationsR Testa, A R Bonfigli, C Pieri, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 3, 2000
Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metforminF Gregorio, F Ambrosi, S Manfrini, et al.
Therapeutic Drug Monitoring|June 12, 1999
Determination of plasma metformin by a new cation-exchange HPLC techniqueA R Bonfigli, S Manfrini, F Gregorio, et al.
European Journal of Nuclear Medicine|July 1, 1997
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolismC Cittanti, P Colamussi, M Giganti, et al.
Pageof 6